Alembic Pharmaceuticals has announced the resignation of Ms. Manisha Saraf from her roles as Company Secretary, Compliance Officer, and Nodal Officer. Her resignation is effective from the close of business hours on August 10, 2026. The company has provided the necessary details as per SEBI regulations, including Ms. Saraf’s resignation letter, which cites the pursuit of a new opportunity aligned with her long-term career aspirations.
Key Management Change at Alembic Pharmaceuticals
Alembic Pharmaceuticals Limited has officially notified the stock exchanges regarding a significant change in its management. Ms. Manisha Saraf has tendered her resignation from the crucial positions of Company Secretary & Compliance Officer, also designated as a Key Managerial Personnel, and Nodal Officer of the company. This change will be effective from the end of the business day on August 10, 2026.
Resignation Details and Rationale
The company has submitted the required disclosures as mandated by Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ms. Saraf’s resignation letter indicates her decision to pursue a new opportunity that better aligns with her professional growth and long-term career objectives. She expressed gratitude for her tenure with the company and extended best wishes for its future endeavors.
The detailed information, as per the SEBI Master Circular, including Ms. Saraf’s brief profile (which is noted as ‘Not Applicable’ in the context of her departure) and disclosure of relationships with directors, has been provided in Annexure A and Annexure B of the filing.
Source: BSE
